Peptides on the WADA Banned List: What Athletes Ne…

The World Anti-Doping Agency (WADA) Prohibited List is updated annually and has steadily expanded its coverage of peptide hormones, growth factors, and mimetics. For competitive athletes subject to WADA's code — which includes most Olympic sports, professional athletics, and many national-level competitions — understanding which peptides are prohibited, how they are detected, and when prohibitions apply is essential for compliance. This guide covers the current state of peptide prohibition in sport.

The WADA Prohibited List: How It Works

WADA's Prohibited List is divided into substances banned in-competition only, substances banned both in- and out-of-competition, and methods. Most peptide hormones fall under Section S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics — banned both in- and out-of-competition for all sports. Some appear under S4: Hormone and Metabolic Modulators.

The list uses class-based prohibition with specific inclusions and an "and related substances" clause — meaning a peptide doesn't have to be individually named to be prohibited if it acts similarly to named substances. This is deliberately broad to prevent circumvention via novel analogs.

Section S2: Key Banned Peptides

Growth Hormone Releasing Hormones (GHRH) and analogs: Sermorelin, CJC-1295, tesamorelin, and related GHRH analogs are explicitly banned. Any peptide that stimulates GH release through the GHRH receptor is covered.

Growth Hormone Releasing Peptides (GHRPs): GHRP-2, GHRP-6, ipamorelin, hexarelin, and all GHRP-class compounds are banned. These stimulate GH release through the ghrelin/GHS-R1a receptor.

Insulin-like Growth Factors: IGF-1 (mecasermin) and its analogs (including long-chain IGF-1 analogs like IGF-1 LR3) are prohibited. IGF-1 is the primary downstream mediator of GH's anabolic effects.

BPC-157: Explicitly named on the current WADA list under S2 as a peptide hormone with growth factor activity. Banned both in- and out-of-competition.

Thymosin beta-4 and fragments: TB-500 (the commercial fragment of thymosin beta-4) and full-length thymosin beta-4 are banned under S2. Several horse racing doping cases involving thymosin beta-4 were documented before formal inclusion on the list.

EPO and erythropoietin peptides: Erythropoietin and its analogs (darbepoetin, CERA, peginesatide) are banned under S2 for their red blood cell-stimulating effects relevant to endurance sport.

Section S4: Hormone and Metabolic Modulators

PT-141 (bremelanotide) does not appear to be explicitly named on the current WADA list, as its performance enhancement mechanism is unclear. Kisspeptin, which modulates testosterone and LH production, falls under the "related substances" principle given its effects on endogenous anabolic hormone production.

Selective androgen receptor modulators (SARMs), while not peptides, are banned under S1 (Anabolic Agents). This is relevant context when comparing peptides to SARMs.

Detection Methods and Windows

WADA maintains a confidential database of validated anti-doping assays. Publicly known detection methods include:

GH secretagogues: Many GHRPs and GHRH analogs are detectable in urine by liquid chromatography-mass spectrometry (LC-MS/MS). Ipamorelin is detectable in urine for approximately 24–48 hours after a single dose. CJC-1295 has a longer half-life and may be detectable for longer periods.

BPC-157: As of current public knowledge, no validated WADA anti-doping assay for BPC-157 has been published. WADA has stated that detection methods are under development. Athletes should assume detection capability will improve.

TB-500: Thymosin beta-4 detection in plasma and urine via immunoassay and LC-MS is technically feasible. Validated methods for competition testing are in development.

Exogenous GH: Detectable via the GH isoform test and biomarker test (IGF-1, P-III-NP). Indirect evidence of GH use persists longer than direct detection.

The Therapeutic Use Exemption (TUE) Process

Some banned peptides have legitimate medical applications that may qualify for a Therapeutic Use Exemption. Teriparatide (PTH 1-34) for osteoporosis treatment is one example — an athlete with documented severe osteoporosis could potentially receive a TUE for teriparatide, though this is unusual given that the anabolic bone effects do not translate to performance advantages in healthy athletes.

TUEs must be applied for in advance through the relevant national anti-doping organization or international federation. The application requires medical documentation, diagnosis, and justification that no permitted alternative exists.

Supplements and Contamination Risk

Peptides are increasingly appearing as undisclosed contaminants in dietary supplements. WADA's strict liability rule means athletes bear responsibility for prohibited substances found in their samples regardless of how they got there. Athletes should use supplement products certified by third-party testing programs (NSF Certified for Sport, Informed-Sport) to minimize contamination risk.

FAQ

Are all peptides banned by WADA? No. Collagen peptides, dietary protein hydrolysates, and many cosmetic or therapeutic peptides not on the S2 list are permitted. The ban targets performance-relevant peptide hormones and growth factors.

If BPC-157 isn't detectable, does it matter if it's banned? Yes. The prohibition applies regardless of current detection capability. WADA's testing is not the only mechanism — information from coaches, teammates, or customs seizures can also trigger investigations. Additionally, detection methods improve annually.

Does the WADA list apply to recreational athletes? Only if you compete in a sport governed by a WADA-adopting body. Recreational athletes training for personal goals without competition face no WADA sanctions but still bear the health and legal risks of unregulated compounds.

Track your supplements in Optimize.

Peptides on the WADA Banned List: What Athletes Need to Know